$224 Million is the total value of Lion Point Capital, LP's 31 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SMTC | SEMTECH CORPcall | $64,375,000 | +1.1% | 2,500,000 | 0.0% | 28.68% | -0.3% | |
| SMTC | SEMTECH CORP | $63,161,016 | +1.1% | 2,452,855 | 0.0% | 28.14% | -0.3% | |
| IWM | New | ISHARES TRput | $29,162,100 | – | 165,000 | +100.0% | 12.99% | – |
| SPY | SPDR S&P 500 ETF TRUSTput | $21,374,000 | -3.6% | 50,000 | 0.0% | 9.52% | -4.9% | |
| Sell | MARINUS PHARMACEUTICALS INC | $17,269,963 | -29.6% | 2,145,337 | -5.0% | 7.70% | -30.5% | |
| ARDX | Sell | ARDELYX INC | $4,800,801 | -7.2% | 1,176,667 | -22.9% | 2.14% | -8.6% |
| BFI | BURGERFI INTERNATIONAL INC | $3,185,288 | -26.1% | 2,745,938 | 0.0% | 1.42% | -27.2% | |
| BATL | BATTALION OIL CORPORATION | $2,353,906 | +8.2% | 380,891 | 0.0% | 1.05% | +6.7% | |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $2,270,103 | +23.4% | 130,691 | 0.0% | 1.01% | +21.6% | |
| INSM | Buy | INSMED INC | $1,775,959 | +67.2% | 70,335 | +39.7% | 0.79% | +64.8% |
| MCRB | SERES THERAPEUTICS INC | $1,646,491 | -50.3% | 691,803 | 0.0% | 0.73% | -51.0% | |
| BLUE | BLUEBIRD BIO INC | $1,615,018 | -7.6% | 531,256 | 0.0% | 0.72% | -8.9% | |
| MIST | MILESTONE PHARMACEUTICALS IN | $1,395,642 | +8.8% | 450,207 | 0.0% | 0.62% | +7.2% | |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $1,228,957 | +12.9% | 82,425 | -17.1% | 0.55% | +11.4% |
| Sell | DURECT CORP | $1,064,363 | -64.3% | 427,455 | -29.0% | 0.47% | -64.8% | |
| MIRM | MIRUM PHARMACEUTICALS INC | $853,200 | +22.1% | 27,000 | 0.0% | 0.38% | +20.3% | |
| FENC | FENNEC PHARMACEUTICALS INC | $826,100 | -14.9% | 110,000 | 0.0% | 0.37% | -16.2% | |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $824,000 | – | 80,000 | +100.0% | 0.37% | – |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $793,901 | -30.3% | 115,898 | +5.5% | 0.35% | -31.3% |
| TVTX | New | TRAVERE THERAPEUTICS INC | $697,320 | – | 78,000 | +100.0% | 0.31% | – |
| New | HUMACYTE INC | $688,550 | – | 235,000 | +100.0% | 0.31% | – | |
| New | TRAVERE THERAPEUTICS INCnote 2.250% 3/0 | $647,930 | – | 1,000,000 | +100.0% | 0.29% | – | |
| REPL | New | REPLIMUNE GROUP INC | $598,850 | – | 35,000 | +100.0% | 0.27% | – |
| SNDX | SYNDAX PHARMACEUTICALS INC | $500,940 | -30.6% | 34,500 | 0.0% | 0.22% | -31.6% | |
| AADI BIOSCIENCE INC | $398,927 | -29.2% | 82,423 | 0.0% | 0.18% | -30.2% | ||
| New | HARPOON THERAPEUTICS INC | $332,306 | – | 82,458 | +100.0% | 0.15% | – | |
| LUMO | Buy | LUMOS PHARMA INC | $299,620 | +15.9% | 90,794 | +15.9% | 0.13% | +14.5% |
| BFIIW | BURGERFI INTERNATIONAL INCcall | $235,428 | -11.4% | 2,083,438 | 0.0% | 0.10% | -12.5% | |
| MSFT | MICROSOFT CORP | $31,575 | -7.3% | 100 | 0.0% | 0.01% | -6.7% | |
| GOOG | ALPHABET INCcap stk cl c | $13,185 | +9.0% | 100 | 0.0% | 0.01% | +20.0% | |
| CVX | New | CHEVRON CORP NEW | $7,757 | – | 46 | +100.0% | 0.00% | – |
| PDCE | Exit | PDC ENERGY INC | $0 | – | -100 | -100.0% | -0.00% | – |
| HARP | Exit | HARPOON THERAPEUTICS INC | $0 | – | -456,514 | -100.0% | -0.15% | – |
| ORGN | Exit | ORIGIN MATERIALS INC | $0 | – | -100,000 | -100.0% | -0.19% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INCcall | $0 | – | -146,000 | -100.0% | -0.22% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -7,400 | -100.0% | -0.34% | – |
| Exit | 2SEVENTY BIO INC | $0 | – | -111,667 | -100.0% | -0.51% | – | |
| OAS | Exit | CHORD ENERGY CORPORATION | $0 | – | -102,403 | -100.0% | -7.12% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CANADIAN SOLAR INC | 21 | Q2 2021 | 25.6% |
| ALCOA CORP | 21 | Q1 2022 | 8.0% |
| ISHARES TR | 19 | Q3 2023 | 39.2% |
| COMSCORE INC | 19 | Q4 2022 | 5.8% |
| HALCON RES CORP | 15 | Q3 2023 | 3.3% |
| KINIKSA PHARMACEUTICALS LTD | 15 | Q3 2023 | 3.1% |
| LUMOS PHARMA INC | 15 | Q3 2023 | 2.8% |
| DURECT CORP | 14 | Q3 2022 | 10.5% |
| ARCONIC INC | 14 | Q1 2020 | 4.4% |
| MARINUS PHARMACEUTICALS INC | 13 | Q3 2023 | 11.6% |
View Lion Point Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SIERRA WIRELESS INC | June 07, 2022 | 1,810,671 | 4.7% |
| BATTALION OIL CORP | February 14, 2022 | 352,851 | 2.2% |
| DURECT CORP | February 14, 2022 | 15,486,004 | 6.8% |
| LUMOS PHARMA, INC. | February 12, 2021 | 407,192 | 4.9% |
| BurgerFi International, Inc. | January 11, 2021 | 2,745,938 | 15.7% |
| Canadian Solar Inc. | November 27, 2020 | 2,453,724 | 4.1% |
| NEWLINK GENETICS CORP | February 14, 2020 | 3,114,733 | 8.3% |
| CARRIZO OIL & GAS INC | October 29, 2019 | 4,584,400 | 5.0% |
| LATTICE SEMICONDUCTOR CORP | July 22, 2019 | 6,467,035 | 4.9% |
| Cimarex Resolute LLC | March 05, 2019 | ? | ? |
View Lion Point Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Lion Point Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.